A Phase 3 trial of HIPEC in Ovarian Cancer

Interval cytoreduction with HIPEC (Hyperthermic Intraperitoneal chemotherapy) signficantly improves Recurrence free survival and overall survival when compared to surgery without HIPEC in stage 3 epithelial ovarian cancer

You can find the abstract here

http://abstracts.asco.org/199/AbstView_199_187460.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s